Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 13 of 20
Macular Damage in Early Glaucoma and Progression
NCT02547740
Ticagrelor Therapy for RefrACTORy Migraine Study
NCT02518464
Quantitative Imaging Biomarkers for Sarcoma
NCT02579980
MRI and PET to Assess Pembrolizumab Response
NCT02591654
2 Dose Neuraxial Morphine for Prevention of PDPH
NCT02473276
Acetaminophen and Post Circumcision Pain Control
NCT02498483
Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia
NCT02506543
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
NCT02513784
EC PK in Women With Normal and Obese BMI
NCT02689804
Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart
NCT02462941
Ultrasound vs Palpation for Infant Lumbar Puncture
NCT02373774
Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children
NCT02358681
Creating Opportunities Through Mentoring, Parenting and Safe Spaces - Democratic Republic of Congo
NCT02384642
Transcranial Direct Current Stimulation for Post-Stroke Aphasia
NCT02461355
Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.
NCT02437669
Effects of CPAP on Diet, Physical Activity, and Cardiovascular Risk
NCT01944020
Microfinance Institutions as a Platform for Global Health
NCT02808117
The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia
NCT05172687
PrEPared and Strong: Clinic-Based PrEP for Black MSM
NCT02167386
Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
NCT02223819
iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology
NCT02731326
Evaluation of Ureteral Patency in the Post-indigo Carmine Era
NCT02677623
Microbiome, Exercise Tracking Study: Among Individuals at High Risk for Colorectal Cancer
NCT02780284
Immediate or Delayed Provisionalization in Posterior Healed Sites
NCT02387970
Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?
NCT04080505
Web-based Validation Pelvic Floor Questionnaires
NCT02724891
Antigen Presentation and Lymphocyte Response in Parkinson's Disease
NCT02939534
Early Behavioral Intervention for Preterm Infants
NCT02379130
Pharmacokinetics of Intranasal Ketorolac in Children
NCT02297906
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
NCT02299297
Closed Suction Drainage in Shoulder Arthroplasty
NCT02767453
Family Nurture Intervention in the CHoNJ NICU
NCT02352142
A Retrospective Comparison of Neonatal Acid-base Status After CD Before January, 2015 and After January, 2016
NCT03455660
Medication Adherence Telemonitoring to Reduce Heart Failure Readmissions
NCT02378571
Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging
NCT02295007
Drug User Internet and Mobile Tech Use
NCT01871298
Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents
NCT02236273
Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
NCT02273219
Sildenafil for Treatment of Choroidal Ischemia
NCT04356716
Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts
NCT02284594
Effect of Acid Suppression Medication on Pediatric Microbiome
NCT02016820
Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults
NCT02347007
Topical Vancomycin for Neurosurgery Wound Prophylaxis
NCT02284126
Impact of Sleep and Meal Timing on Food Intake Regulation
NCT02347020
Neonatal Acid-Base Status After C Section With Maternal Tilt vs. Supine
NCT02243423
ACTHar in the Treatment of Lupus Nephritis
NCT02226341
Bone Mass and Strength After Kidney Transplantation
NCT02224144
N-of-1 Trials for Blood Pressure Medications in Adults
NCT02744456
Use of Prineo in Breast Reduction Surgery
NCT01996917
Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain
NCT01846221
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.